IEQ Capital’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.44M Sell
321,330
-26,795
-8% -$300K 0.01% 635
2026
Q2
$3.82M Buy
348,125
+66,221
+23% +$625K 0.02% 584
2026
Q1
$2.29M Sell
281,904
-116,551
-29% -$1M 0.01% 720
2025
Q4
$4.14M Buy
398,455
+124,369
+45% +$1.3M 0.01% 572
2025
Q3
$2.43M Buy
274,086
+131,279
+92% +$936K 0.01% 697
2025
Q2
$824K Buy
142,807
+44,876
+46% +$275K 0.01% 927
2025
Q1
$646K Buy
+97,931
New +$763K 0.01% 882

Other funds holding KURA

IEQ Capital's KURA Position: Q3 2026 in Review

IEQ Capital reduced its Kura Oncology (KURA) stake by 7.7% in Q3 2026, selling an estimated $300K and leaving 321,330 shares worth $3.44M. The position accounts for 0.01% of the portfolio, ranked #635.

IEQ Capital first reported a position in KURA in Q1 2025 and has held it in 7 quarters since. The position peaked at $4.14M in Q4 2025. 233 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • IEQ Capital held 321,330 shares of Kura Oncology worth $3.44M as of Q3 2026.
  • IEQ Capital sold 26,795 Kura Oncology shares in Q3 2026, an estimated $300K.
  • Kura Oncology made up 0.01% of IEQ Capital's portfolio in Q3 2026, its #635 holding.
  • IEQ Capital first reported a position in Kura Oncology in Q1 2025 and has held it in 7 quarters since.
  • IEQ Capital's Kura Oncology position peaked at $4.14M in Q4 2025.
  • 233 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.